V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280010443 | 280012106 | 1.78 | null | Palliative (P) | 2014-06-09 | 2014-07-18 | Carboplatin + Etoposide IV 3 day | 02 | N | 280028678 | CARBOPLATIN + ETOPOSIDE |
| 280010444 | 280010644 | null | null | null | 2017-12-17 | 2017-12-17 | Carboplatin + Etoposide IV 3 day | N | N | 280028683 | CARBOPLATIN + ETOPOSIDE |
| 280010445 | 280005976 | 1.66 | 43.7 | Palliative (P) | 2017-07-15 | 2017-07-21 | Carboplatin + Etoposide IV 3 day | 02 | N | 280028685 | CARBOPLATIN + ETOPOSIDE |
| 280010446 | 280009128 | 1.7 | null | Curative (C) | 2013-07-03 | 2013-07-18 | Cetuximab +Cisplatin + FU (Cycle 1) | N | N | 280028686 | CETUXIMAB + CISPLATIN + FU |
| 280010447 | 280005978 | 1.66 | 103.9 | Curative (C) | 2017-10-14 | 2017-10-19 | VAI (Ifos 3g/m2) | null | N | 280028693 | VAI |
| 280010448 | 280010646 | 1.56 | 80.1 | null | null | 2018-08-26 | ETOPOSIDE + IFOSFAMIDE | Y | N | 280028697 | ETOPOSIDE + IFOSFAMIDE |
| 280010449 | 280005980 | 1.82 | 102.1 | Adjuvant (A) | 2015-05-12 | 2015-05-24 | Etoposide + Ifosfamide (3 days) | N | N | 280028697 | ETOPOSIDE + IFOSFAMIDE |
| 280010450 | 280010648 | null | 102 | Palliative (P) | 2013-03-31 | 2014-05-09 | VAI (Ifos 3g/m2) | 01 | N | 280028712 | VAI |
| 280010451 | 280005985 | 1.59 | 48 | Neo-adjuvant (N) | 2017-02-06 | 2017-02-06 | DE-ESCALATE TRIAL | N | null | 280028715 | DE-ESCALATE TRIAL |
| 280010452 | 280005986 | 1.76 | 74.1 | Curative (C) | 2015-04-08 | 2015-04-23 | Doxorubicin + Ifosfamide | N | N | 280028735 | DOXORUBICIN + IFOSFAMIDE |
| 280010453 | 280005988 | 1.66 | 92.4 | Curative (C) | 2018-03-05 | 2018-03-31 | VAI (Ifos 3g/m2) | N | N | 280028736 | IRINOTECAN + MDG |
| 280010454 | 280009136 | null | 84.9 | Palliative (P) | 2015-04-18 | 2015-05-06 | CISPLATIN + FLUOROURACIL | 2 | N | 280028739 | CISPLATIN + FLUOROURACIL |
| 280010455 | 280005993 | 1.59 | 72.1 | Palliative (P) | 2015-07-27 | 2015-07-27 | Carboplatin + Etoposide IV 3 day | 02 | N | 280028746 | CARBOPLATIN + ETOPOSIDE |
| 280010456 | 280005994 | 1.78 | 56.7 | Curative (C) | 2013-02-04 | 2013-08-28 | Irinotecan + Temozolomide | N | N | 280028749 | IRINOTECAN + TEMOZOLOMIDE |
| 280010457 | 280005996 | 1.63 | 67.8 | Palliative (P) | 2017-06-23 | 2017-06-23 | Carboplatin + Etoposide IV 3 day | 2 | N | 280028760 | CARBOPLATIN + ETOPOSIDE |
| 280010458 | 280005997 | 1.65 | 50 | Palliative (P) | 2018-05-16 | 2018-05-24 | EW EuroEwing 99 : VActI | N | N | 280028764 | EURO-EWING |
| 280010459 | 280010651 | 0 | null | Adjuvant (A) | 2015-11-11 | 2015-11-17 | Carboplatin + Etoposide iv&po | N | N | 280028765 | CARBOPLATIN + ETOPOSIDE |
| 280010460 | 280006003 | 1.84 | 79.5 | Palliative (P) | 2017-12-01 | 2017-12-11 | Cetuximab+Cisplatin+FU (> Cycle 2) | 02 | N | 280028780 | CETUXIMAB + CISPLATIN + FU |
| 280010461 | 280006005 | 1.61 | 68.2 | Curative (C) | 2016-08-23 | 2016-10-12 | Irinotecan + Temozolomide | N | null | 280028794 | IRINOTECAN + TEMOZOLOMIDE |
| 280010462 | 280009143 | 1.85 | null | Palliative (P) | 2015-12-23 | 2015-12-24 | Doxorubicin + Olaratumab | N | N | 280028797 | DOXORUBICIN + OLARATUMAB |
| 280010463 | 280006009 | 1.73 | 92 | Neo-adjuvant (N) | 2016-12-04 | 2017-01-20 | Gemcitabine weekly | 02 | N | 280028798 | GEMCITABINE |
| 280010464 | 280006009 | 1.75 | 68 | Palliative (P) | 2014-09-16 | 2014-10-07 | CARBOPLATIN + PACLITAXEL | N | N | 280028798 | CARBOPLATIN + PACLITAXEL |
| 280010465 | 280006010 | 1.74 | 76 | Palliative (P) | 2014-11-26 | 2014-12-07 | Doxorubicin + Ifosfamide | Y | N | 280028813 | DOXORUBICIN + IFOSFAMIDE |
| 280010466 | 280006012 | 1.83 | null | Curative (C) | 2013-01-24 | 2014-02-17 | Cetuximab+Cisplatin+FU (> Cycle 2) | N | N | 280028814 | CETUXIMAB + CISPLATIN + FU |
| 280010467 | 280006014 | 1.64 | null | Curative (C) | 2014-02-12 | 2014-02-25 | Carboplatin + Etoposide IV 3 day | N | N | 280028817 | CARBOPLATIN + ETOPOSIDE |
| 280010468 | 280006014 | 1.53 | 66 | Curative (C) | 2017-10-24 | 2017-10-24 | EW EuroEwing 2012 Arm A VIDE | N | N | 280028817 | EURO-EWING |
| 280010469 | 280006016 | 1.6 | 67.4 | Palliative (P) | 2017-06-18 | 2017-07-03 | DE-ESCALATE TRIAL | null | null | 280028834 | DE-ESCALATE TRIAL |
| 280010470 | 280006017 | 1.64 | 62.3 | Palliative (P) | 2016-12-11 | 2017-01-15 | CAV | N | N | 280028836 | CAV |
| 280010471 | 280006020 | 1.8 | 24.45 | Palliative (P) | 2014-08-19 | 2015-01-13 | Doxorubicin + Ifosfamide | N | null | 280028851 | DOXORUBICIN + IFOSFAMIDE |
| 280010472 | 280009151 | 1.66 | 55.1 | Palliative (P) | 2017-07-10 | 2017-07-10 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | null | 280028855 | CISPLATIN + GEMCITABINE |
| 280010473 | 280006023 | 1.7 | 59.7 | Curative (C) | 2016-08-27 | 2016-09-04 | Cisplatin + Gemcitabine (D 1 & 8) | 2 | N | 280028857 | CISPLATIN + GEMCITABINE |
| 280010474 | 280006025 | 1.76 | 101.4 | Palliative (P) | 2017-04-23 | 2017-05-14 | Etoposide + Ifosfamide (3 days) | 2 | N | 280028860 | ETOPOSIDE + IFOSFAMIDE |
| 280010475 | 280006029 | null | 77 | Adjuvant (A) | 2017-06-23 | 2017-06-23 | DE-ESCALATE TRIAL | 02 | N | 280028863 | DE-ESCALATE TRIAL |
| 280010476 | 280006030 | 1.78 | null | Palliative (P) | 2013-10-09 | 2013-11-08 | Doxorubicin + Ifosfamide | N | null | 280028864 | DOXORUBICIN + IFOSFAMIDE |
| 280010477 | 280006033 | 1.73 | 88.2 | Adjuvant (A) | 2013-09-22 | 2013-09-23 | Doxorubicin + Olaratumab | N | N | 280028865 | DOXORUBICIN + OLARATUMAB |
| 280010478 | 280006035 | 1.63 | 57.4 | Curative (C) | 2017-09-17 | 2017-09-17 | DE-ESCALATE TRIAL | 02 | null | 280028879 | DE-ESCALATE TRIAL |
| 280010479 | 280009160 | 1.6 | 102.7 | Palliative (P) | 2014-06-01 | 2014-06-08 | Doxorubicin + Ifosfamide | N | N | 280028880 | DOXORUBICIN + IFOSFAMIDE |
| 280010480 | 280006038 | 1.7 | 84 | Palliative (P) | 2017-04-14 | 2017-05-10 | CARBOPLATIN + PACLITAXEL | N | N | 280028918 | CARBOPLATIN + PACLITAXEL |
| 280010481 | 280009162 | 1.75 | null | Palliative (P) | 2018-12-22 | 2019-02-21 | GEMCITABINE | null | null | 280028918 | GEMCITABINE |
| 280010482 | 280011755 | 1.77 | 72.4 | Palliative (P) | 2014-01-22 | 2014-01-26 | Doxorubicin + Ifosfamide | 2 | N | 280028921 | DOXORUBICIN + IFOSFAMIDE |
| 280010483 | 280006040 | 1.61 | 62.3 | Palliative (P) | 2014-05-29 | 2014-06-01 | EURO-EWING | 02 | null | 280028924 | EURO-EWING |
| 280010484 | 280009164 | 1.5 | 75 | Palliative (P) | 2016-06-11 | 2016-06-14 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 280028929 | GEMCITABINE |
| 280010485 | 280006045 | 1.67 | 79 | Palliative (P) | 2016-07-30 | 2016-08-05 | EW EuroEwing 99 : VActI | 2 | N | 280028950 | EURO-EWING |
| 280010486 | 280006047 | 1.55 | 63.9 | Curative (C) | 2013-06-18 | 2013-06-21 | IRINOTECAN + TEMOZOLOMIDE | 02 | null | 280028957 | VAI |
| 280010487 | 280010664 | 1.82 | 92.8 | Palliative (P) | 2015-03-14 | 2015-03-14 | Sunitinib | 2 | N | 280028961 | IRINOTECAN |
| 280010488 | 280006048 | 1.59 | 54.2 | Palliative (P) | 2018-11-04 | 2018-12-09 | Cyclophosphamide PO +Vinorelbine IV | N | N | 280028965 | IPILIMUMAB |
| 280010489 | 280010666 | null | null | Disease modification (D) | 2018-05-26 | 2018-09-07 | IVADo | null | null | 280028979 | CAPECITABINE |
| 280010490 | 280006051 | 1.7 | 108.3 | Palliative (P) | 2018-08-11 | 2018-08-11 | Capecitabine + Mitomycin | N | N | 280028985 | CAPECITABINE + OXALIPLATIN |
| 280010491 | 280006052 | 1.74 | 82 | Curative (C) | 2016-11-01 | 2016-11-21 | Carboplatin + Topotecan | N | Y | 280028989 | CAPECITABINE + IRINOTECAN |
| 280010492 | 280006055 | null | 64.45 | Palliative (P) | 2017-01-22 | 2017-01-22 | LIPOSOMAL DOXORUBICIN | N | N | 280028992 | CAPECITABINE + MITOMYCIN |